Sector Chart Madrigal Pharmaceuticals, Inc.
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 553.48 USD | +1.46% |
|
+3.13% | -4.96% |
| 07-13 | Madrigal Pharmaceuticals' Three New Patents Support Patent Extension Into 2045, Truist Says | MT |
| 07-13 | Madrigal Pharmaceuticals Expands Rezdiffra Patent Protection With Three New Patents | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 12.76B | - | ||||
| 53.83B | |||||
| 52.1B | |||||
| 23.48B | - | ||||
| 23.13B | - | ||||
| 19.36B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
